Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
iShares MSCI Emerging Markets ETF
EEM
$31B
| $230K | ﹤0.01% |
4,200
-18,600
| -82% | -$1.01M |
2025 Q2
2 quarters
|
|
2852
Northwest Bancshares
NWBI
$2.15B
| $229K | ﹤0.01% |
19,069
-206,172
| -92% | -$2.51M |
2024 Q3
5 quarters
|
|
2853
Inuvo
INUV
$8.51M
| $228K | ﹤0.01% |
91,841
+4,300
| +5% | +$12.4K |
2021 Q4
16 quarters
|
|
|
UROY
2854
Uranium Royalty Corp
UROY
$1.59B
| $227K | ﹤0.01% |
+64,200
| New | +$251K |
2025 Q4
0 quarters
|
|
|
NSTS
2855
DELISTED
NSTS Bancorp
NSTS
| $227K | ﹤0.01% |
17,497
+3,097
| +22% | +$35.3K |
2024 Q4
4 quarters
|
|
|
CBK
2856
Commercial Bancgroup
CBK
$423M
| $226K | ﹤0.01% |
+9,200
| New | +$226K |
2025 Q4
0 quarters
|
|
|
SVC
2857
Service Properties Trust
SVC
$926M
| $225K | ﹤0.01% |
24,480
+2,400
| +11% | +$24.1K |
2024 Q4
4 quarters
|
|
2858
Trupanion
TRUP
$1.14B
| $224K | ﹤0.01% |
+6,000
| New | +$236K |
2025 Q4
0 quarters
|
|
2859
Elicio Therapeutics
ELTX
$49.7M
| $224K | ﹤0.01% |
28,111
-20,560
| -42% | -$187K |
2025 Q3
1 quarter
|
|
2860
First Trust Cloud Computing ETF
SKYY
$3.55B
| $221K | ﹤0.01% |
+1,700
| New | +$227K |
2025 Q4
0 quarters
|
|
2861
Enlivex Ltd
ENLV
$5.06M
| $221K | ﹤0.01% |
20,909
+10,423
| +99% | +$155K |
2016 Q2
38 quarters
|
|
2862
Xilio Therapeutics
XLO
$59.6M
| $220K | ﹤0.01% |
24,601
+9,980
| +68% | +$105K |
2022 Q2
14 quarters
|
|
2863
Verrica Pharmaceuticals
VRCA
$70.6M
| $219K | ﹤0.01% |
26,400
-2,791
| -10% | -$15.5K |
2025 Q2
2 quarters
|
|
2864
GameSquare
GAME
$41M
| $219K | ﹤0.01% |
71,138
+4,375
| +7% | +$20.2K |
2025 Q1
3 quarters
|
|
|
TONX
2865
TON Strategy Co
TONX
$177M
| $218K | ﹤0.01% |
+109,400
| New | +$400K |
2025 Q4
0 quarters
|
|
2866
Avalon Holdings
AWX
$9.63M
| $217K | ﹤0.01% |
80,510
+300
| +0.4% | +$816 |
2019 Q4
24 quarters
|
|
2867
Rezolute
RZLT
$471M
| $216K | ﹤0.01% |
+91,461
| New | +$717K |
2025 Q4
0 quarters
|
|
2868
NET Power
NPWR
$109M
| $216K | ﹤0.01% |
+94,600
| New | +$296K |
2025 Q4
0 quarters
|
|
2869
Koppers
KOP
$821M
| $214K | ﹤0.01% |
7,900
-19,400
| -71% | -$543K |
2023 Q1
11 quarters
|
|
|
HIT
2870
Health In Tech Inc
HIT
$48.4M
| $214K | ﹤0.01% |
+134,317
| New | +$293K |
2025 Q4
0 quarters
|
|
2871
Entera Bio
ENTX
$462M
| $210K | ﹤0.01% |
108,001
+19,601
| +22% | +$46K |
2022 Q3
13 quarters
|
|
2872
Escalade
ESCA
$257M
| $210K | ﹤0.01% |
15,530
| – | – |
2013 Q2
50 quarters
|
|
2873
Willamette Valley Vineyards
WVVI
$10.5M
| $209K | ﹤0.01% |
68,652
-3,500
| -5% | -$10.9K |
2013 Q3
49 quarters
|
|
2874
Alpha and Omega Semiconductor
AOSL
$845M
| $208K | ﹤0.01% |
+10,500
| New | +$248K |
2025 Q4
0 quarters
|
|
|
JCTC
2875
Jewett-Cameron Trading
JCTC
$10.2M
| $208K | ﹤0.01% |
92,328
-5,800
| -6% | -$15.9K |
2013 Q2
50 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.